Pfizer front runner to clinch Strides Arcolab’s specialty biz for $1.7B
11 September, 2012
Global pharmaceutical manufacturer Pfizer is in advanced talks with Strides Arcolab to buy its specialty business housing injectable drug unit for $1.7 billion (Rs 9,460 crore), three people with ...
TO READ THE FULL STORY
The only platform exclusively covering Private Investments in India.
Exclusive reporting, expert analyses and commentary on PE/VC/M&A deals and dealmakers
Daily, weekly and monthly curated newsletters on the alternative investment ecosystem in India
Participation in VCCircle Marquee events at concessional rates
Latest VCCEdge annual, quarterly and industry reports
Comprehensive | Accurate | Unbiased | Impeccably sourced